• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
OPT

OPTHEA LIMITED

0.00% ! 60.0¢
Market Cap $738.7M  !
Healthcare Biotechnology
Add to My Watchlist

Opthea Limited is an Australia-based clinical-stage biopharmaceutical company. The... Opthea Limited is an Australia-based clinical-stage biopharmaceutical company. The Company is engaged in developing novel therapies to address the unmet need in the treatment of prevalent and progressive retinal diseases, including wet age-related macular degeneration (wet AMD) and diabetic macular edema (DME). Its lead product candidate, sozinibercept (OPT-302), is being evaluated in two pivotal Phase 3 clinical trials for use in combination with standard-of-care anti-VEGF-A monotherapies for the treatment of wet AMD and DME. The Company has also manufactured OPT-302 for use in Phase III clinical trials, conducts activities to support the commercialization of the product and expanded its management team in the United States to facilitate broader oversight and execution of its Phase III program. Its development activities are based on an intellectual property portfolio covering key targets (Vascular Endothelial Growth Factors VEGF-C, VEGF-D and VEGF Receptor-3).More

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
OPT
Ann: Opthea Announces Decision to Discontinue Wet AMD Trials
2 3
14/06/25 158 77K
14/06/25 Last post  Weazel Comments Created with Sketch.  158  Views Created with Sketch.  77K 
OPT
opt shareholders deserve a conference call 		02/06/25 42 32K
02/06/25 Last post  Tradinator Comments Created with Sketch.  42  Views Created with Sketch.  32K 
OPT
Ann: Final Director's Interest Notice Quinton Oswald 		02/06/25 0 317
02/06/25 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  317 
OPT
Ann: Final Director's Interest Notice Dr Susan Orr 		02/06/25 0 269
02/06/25 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  269 
OPT
Ann: Final Director's Interest Notice Dr Julia Haller 		02/06/25 0 229
02/06/25 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  229 
OPT
Ann: Final Director's Interest Notice Anshul Thakral 		02/06/25 0 214
02/06/25 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  214 
OPT
Ann: Opthea Provides Corporate Update 		02/06/25 0 827
02/06/25 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  827 
OPT
Ann: Ceasing to be a substantial holder 		16/05/25 3 3.4K
16/05/25 Last post  Boffin99 Comments Created with Sketch.  3  Views Created with Sketch.  3.4K 

See All Discussions arrow Created with Sketch.

Timeline

Final Director's Interest Notice Quinton Oswald
02 Jun 09:14
 
Final Director's Interest Notice Dr Susan Orr
02 Jun 09:13
 
Final Director's Interest Notice Dr Julia Haller
02 Jun 09:13
 
Final Director's Interest Notice Anshul Thakral
02 Jun 09:13
 
Opthea Provides Corporate Update
02 Jun 08:44
 
Ceasing to be a substantial holder
12 May 08:10
 
View More arrow Created with Sketch.

Featured News

NEWS High-Grade Assays Confirm Multiple Parallel Zones at Golden Eye
right-arrow Created with Sketch.
WCE West Coast Silver Identifies Shallow High-Grade Mineralisation in Early Drilling
right-arrow Created with Sketch.
NEWS Building Permits Received for Phase One Renewable Power Plant
right-arrow Created with Sketch.
NEWS Anson Completes Maiden JORC Mineral Resources Estimate at Green River Lithium Project
right-arrow Created with Sketch.
NEWS Argenica Receives FDA Investigational New Drug Application Update
right-arrow Created with Sketch.
NEWS Listen: HotCopper Wire Podcast 013 - They changed the IPO rules (and that's a good thing)
right-arrow Created with Sketch.
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
(20min delay)
Last
60.0¢ 		Change
0.000(0.00%) 		Mkt cap ! $738.7M
Open High Low Value Volume
0.0¢ 0.0¢ 0.0¢ $0 0
OPT (ASX) Chart

Top Stories

Clinuvel shares dip, even as CEO comes back from temp leave

After Clinuvel's (ASX:CUV) CEO Dr. Philippe Wolgen took time off back in March to respond to an "acute medical condition," it wasn't...
Zip's stunning comeback: Is this the start of a $14 revival? Just when the market had written it off… Zip Co (ASX: ZIP) has come roaring back to life. The Buy Now, Pay Later company stunned investors last Wednesday with a 15% surge in its share price soon after upgrading its full-year earnings forecast to at least $160 million @ up from $153 million...
HotCopper Highlights, Week 24: Israel boosts Energy; Meeka eyes production & Mag7 back Good Afternoon and welcome to HotCopper Highlights for Week 24 of the year, I’m Jon Davidson. In this segment we look at some of the...
Week 24 Wrap: WW3 looms (again); US econ data tepid & silver surfing By and large, I don't think I'd be without peers when I said the biggest thing that happened this week was on energy markets.
ASX Ltd notches upward on sale of company meant to fix CHESS 3 years ago ASX Ltd (ASX:ASX) has notched fractional gains in early Friday trades on the news it's ditched its shareholdings in...

Featured News

NEWS Argenica Receives FDA Investigational New Drug Application Update
right-arrow Created with Sketch.
NEWS Building Permits Received for Phase One Renewable Power Plant
right-arrow Created with Sketch.
NEWS Listen: HotCopper Wire Podcast 013 - They changed the IPO rules (and that's a good thing)
right-arrow Created with Sketch.
WCE West Coast Silver Identifies Shallow High-Grade Mineralisation in Early Drilling
right-arrow Created with Sketch.
VMM Viridis Selected for BNDES and FINEP Strategic Mineral Funding to Advance Colossus Project
right-arrow Created with Sketch.
NEWS Galactica Drilling Program Complete as Blue Star Transitions to Commercial Production
right-arrow Created with Sketch.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.